Mediclinic International PLC (LON:MDC) insider Alan Grieve purchased 1,152 shares of the firm’s stock in a transaction that occurred on Monday, November 28th. The shares were bought at an average price of GBX 734 ($9.11) per share, for a total transaction of £8,455.68 ($10,489.62).

Mediclinic International PLC (LON:MDC) opened at 703.00 on Tuesday. The stock’s 50 day moving average price is GBX 845.21 and its 200 day moving average price is GBX 949.09. The stock’s market cap is GBX 5.18 billion. Mediclinic International PLC has a 52 week low of GBX 701.95 and a 52 week high of GBX 1,174.00.

The company also recently declared a dividend, which will be paid on Monday, December 12th. Stockholders of record on Thursday, November 24th will be paid a GBX 3.20 ($0.04) dividend. This represents a dividend yield of 0.41%. The ex-dividend date of this dividend is Thursday, November 24th.

COPYRIGHT VIOLATION WARNING: This report was first posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are viewing this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The legal version of this report can be viewed at https://www.thecerbatgem.com/2016/11/29/mediclinic-international-plc-mdc-insider-alan-grieve-acquires-1152-shares.html.

A number of analysts have weighed in on MDC shares. Jefferies Group reduced their target price on Mediclinic International PLC from GBX 812 ($10.07) to GBX 741 ($9.19) and set a “hold” rating on the stock in a research note on Tuesday. Macquarie reduced their target price on Mediclinic International PLC from GBX 970 ($12.03) to GBX 830 ($10.30) and set a “neutral” rating on the stock in a research note on Wednesday, November 23rd. Credit Suisse Group AG reduced their target price on Mediclinic International PLC from GBX 1,120 ($13.89) to GBX 1,045 ($12.96) and set an “outperform” rating on the stock in a research note on Friday, November 11th. HSBC reduced their target price on Mediclinic International PLC from GBX 920 ($11.41) to GBX 745 ($9.24) and set a “reduce” rating on the stock in a research note on Friday, November 11th. Finally, Citigroup Inc. lowered Mediclinic International PLC to a “neutral” rating and set a GBX 1,090 ($13.52) target price on the stock. in a research note on Monday, September 12th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company. Mediclinic International PLC currently has an average rating of “Hold” and an average price target of GBX 933.33 ($11.58).

Mediclinic International PLC Company Profile

Mediclinic International plc, formerly Al Noor Hospitals Group plc, is a holding company. The Company operates as an international private healthcare provider. Its segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services.

Receive News & Stock Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related stocks with our FREE daily email newsletter.